{"id":1235,"date":"2016-09-11T15:28:36","date_gmt":"2016-09-11T15:28:36","guid":{"rendered":"https:\/\/stage.datumdental.wee.co.il\/?p=1235"},"modified":"2019-03-10T15:10:10","modified_gmt":"2019-03-10T15:10:10","slug":"ossix-volumax-new-collagen-scaffold-for-gbr-and-gtr-with-improved-volume-maintaining-features-receives-fda-510k-clearance-2","status":"publish","type":"post","link":"https:\/\/stage.datumdental.wee.co.il\/en\/ossix-volumax-new-collagen-scaffold-for-gbr-and-gtr-with-improved-volume-maintaining-features-receives-fda-510k-clearance-2\/","title":{"rendered":"OSSIX\u00ae VOLUMAX \u2014 New Collagen Scaffold for GBR and GTRwith Improved Volume Maintaining Features \u2014 Receives FDA 510(k) Clearance"},"content":{"rendered":"

Lod, Israel and AAP San Diego, CA, September 11th 2016, \/PRNewswire\/– Datum Dental announced that OSSIX\u00ae VOLUMAX has received FDA 510(k) clearance, enabling the company to commercially market this new volumizing (approx. 2 mm), resorbable collagen scaffold in the USA. It is the newest addition to the OSSIX\u00ae line of dental regeneration products for use in periodontics, oral surgery, dental Implantology and dental aesthetic procedures.<\/p>\n

Data presented at the American Association of Periodontology (AAP) Annual Meeting Research Forum Poster Session today, clearly demonstrates statistically significant improved bone growth using OSSIX\u00ae VOLUMAX vs. empty controls.
\nThe results also show OSSIX\u00ae VOLUMAX\u2019 mineralization and ossification progress.<\/p>\n

Yuval Zubery, D.M.D., specialist in periodontics and Chief Medical Officer at Datum Dental, led the study and presented the findings during the poster session. Dr. Zubery will also be delivering an oral presentation at the European Association of Osseointegration (EAO) to be held later this month in Paris.
\nDr. Zubery believes that OSSIX\u00ae VOLUMAX has significant potential to restore lost volume in guided bone regeneration (GBR), guided tissue regeneration (GTR) and soft tissue augmentation cases. \u201cIn implant surgery procedures where there is missing buccal bone, residual dehiscence or buccal dehiscence, this new thick collagen matrix is expected to restore volume. I foresee that clinicians may choose OSSIX\u00ae VOLUMAX for use in the esthetic zone as well, especially for masking implants.\u201d<\/p>\n

Mr. Itay Itzhaky, Chairman at Datum Dental said: \u201cThe new OSSIX\u00ae VOLUMAX and the well-known and decade-long proven OSSIX\u00ae PLUS both feature GLYMATRIX\u00ae. This proprietary technology uses sugars to cross-link collagen molecules, producing a collagen matrix which can be bio-programmed and tailored to deliver a range of products of varying physical properties, customized longevity and controlled rates of degradation. Over 100 publications have been published to date. We will continue to develop products featuring this unique technology, for the benefit of patients and healthcare around the globe.\u201d<\/p>\n

OSSIX\u00ae VOLUMAX is currently available in the USA (via OraPharma) and Korea (via Purgo Biologics). OSSIX\u00ae VOLUMAX is pending the CE mark, Health Canada license and MOH Israel certificate.
\nOSSIX\u00ae VOLUMAX is currently available in 4 sizes, ranging from 10 x 12.5 mm to 30 X 40 mm. For full product details, instructions for use and indications and contraindications, please visit http:\/\/www.ossixdental.com\/products\/ossix-volumax<\/p>\n

About Datum Dental
\nDatum Dental Ltd., a subsidiary of Datum Biotech, was established in 2012 in order to develop, manufacture and market a full line of biomaterials for maxillofacial bone and soft tissue augmentation and regeneration.
\nDatum Dental\u2019s technology (GLYMATRIX\u00ae) is based on over 25 years of research, development, manufacturing and marketing research. Hundreds of thousands of procedures have been performed using GLYMATRIX\u00ae based products in the dental and aesthetic fields, with an excellent record of efficacy and safety. The GLYMATRIX\u00ae technology is a highly controlled and predictable technology which produces a collagen matrix with optimized bio-durability, high biocompatibility and excellent tissue regeneration properties.<\/p>\n

Contact:
\ninfo @ ossixdental.com
\nUSA: www.ossixdental.com
\nOutside USA: www.ossix-dental.com
\nTwitter: @ossixdental
\nLinkedIn: www.linkedin.com\/company\/datum-dental<\/p>\n","protected":false},"excerpt":{"rendered":"

Lod, Israel and AAP San Diego, CA, September 11th 2016, \/PRNewswire\/– Datum Dental announced that OSSIX\u00ae VOLUMAX has received FDA 510(k) clearance, enabling the company to commercially market this new volumizing (approx. 2 mm), resorbable collagen scaffold in the USA. It is the newest addition to the OSSIX\u00ae line of dental regeneration products for use […]<\/p>\n","protected":false},"author":3,"featured_media":2002,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[53],"tags":[],"yoast_head":"\nOSSIX\u00ae VOLUMAX \u2014 New Collagen Scaffold for GBR and GTRwith Improved Volume Maintaining Features \u2014 Receives FDA 510(k) Clearance - Regenerative Solutions | Dentsply Sirona<\/title>\n<meta name=\"description\" content=\"Lod, Israel and AAP San Diego, CA, September 11th 2016, \/PRNewswire\/-- Datum Dental announced that OSSIX\u00ae VOLUMAX has received FDA 510(k) clearance, enabling the company to commercially market\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/stage.datumdental.wee.co.il\/en\/ossix-volumax-new-collagen-scaffold-for-gbr-and-gtr-with-improved-volume-maintaining-features-receives-fda-510k-clearance-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OSSIX\u00ae VOLUMAX \u2014 New Collagen Scaffold for GBR and GTRwith Improved Volume Maintaining Features \u2014 Receives FDA 510(k) Clearance - Regenerative Solutions | Dentsply Sirona\" \/>\n<meta property=\"og:description\" content=\"Lod, Israel and AAP San Diego, CA, September 11th 2016, \/PRNewswire\/-- Datum Dental announced that OSSIX\u00ae VOLUMAX has received FDA 510(k) clearance, enabling the company to commercially market\" \/>\n<meta property=\"og:url\" content=\"https:\/\/stage.datumdental.wee.co.il\/en\/ossix-volumax-new-collagen-scaffold-for-gbr-and-gtr-with-improved-volume-maintaining-features-receives-fda-510k-clearance-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Regenerative Solutions | Dentsply Sirona\" \/>\n<meta property=\"article:published_time\" content=\"2016-09-11T15:28:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-03-10T15:10:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/stage.datumdental.wee.co.il\/wp-content\/uploads\/2016\/09\/ossix-volumax.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"896\" \/>\n\t<meta property=\"og:image:height\" content=\"632\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Steve\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Steve\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/stage.datumdental.wee.co.il\/en\/ossix-volumax-new-collagen-scaffold-for-gbr-and-gtr-with-improved-volume-maintaining-features-receives-fda-510k-clearance-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/stage.datumdental.wee.co.il\/en\/ossix-volumax-new-collagen-scaffold-for-gbr-and-gtr-with-improved-volume-maintaining-features-receives-fda-510k-clearance-2\/\"},\"author\":{\"name\":\"Steve\",\"@id\":\"https:\/\/stage.datumdental.wee.co.il\/en\/#\/schema\/person\/6718398796ad644a693f2686ccfc7828\"},\"headline\":\"OSSIX\u00ae VOLUMAX \u2014 New Collagen Scaffold for GBR and GTRwith Improved Volume Maintaining Features \u2014 Receives FDA 510(k) Clearance\",\"datePublished\":\"2016-09-11T15:28:36+00:00\",\"dateModified\":\"2019-03-10T15:10:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/stage.datumdental.wee.co.il\/en\/ossix-volumax-new-collagen-scaffold-for-gbr-and-gtr-with-improved-volume-maintaining-features-receives-fda-510k-clearance-2\/\"},\"wordCount\":514,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/stage.datumdental.wee.co.il\/en\/#organization\"},\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/stage.datumdental.wee.co.il\/en\/ossix-volumax-new-collagen-scaffold-for-gbr-and-gtr-with-improved-volume-maintaining-features-receives-fda-510k-clearance-2\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/stage.datumdental.wee.co.il\/en\/ossix-volumax-new-collagen-scaffold-for-gbr-and-gtr-with-improved-volume-maintaining-features-receives-fda-510k-clearance-2\/\",\"url\":\"https:\/\/stage.datumdental.wee.co.il\/en\/ossix-volumax-new-collagen-scaffold-for-gbr-and-gtr-with-improved-volume-maintaining-features-receives-fda-510k-clearance-2\/\",\"name\":\"OSSIX\u00ae VOLUMAX \u2014 New Collagen Scaffold for GBR and GTRwith Improved Volume Maintaining Features \u2014 Receives FDA 510(k) Clearance - Regenerative Solutions | Dentsply Sirona\",\"isPartOf\":{\"@id\":\"https:\/\/stage.datumdental.wee.co.il\/en\/#website\"},\"datePublished\":\"2016-09-11T15:28:36+00:00\",\"dateModified\":\"2019-03-10T15:10:10+00:00\",\"description\":\"Lod, Israel and AAP San Diego, CA, September 11th 2016, \/PRNewswire\/-- Datum Dental announced that OSSIX\u00ae VOLUMAX has received FDA 510(k) clearance, enabling the company to commercially market\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/stage.datumdental.wee.co.il\/en\/ossix-volumax-new-collagen-scaffold-for-gbr-and-gtr-with-improved-volume-maintaining-features-receives-fda-510k-clearance-2\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/stage.datumdental.wee.co.il\/en\/#website\",\"url\":\"https:\/\/stage.datumdental.wee.co.il\/en\/\",\"name\":\"Regenerative Solutions | Dentsply Sirona\",\"description\":\"Regenerative Solutions | Dentsply Sirona\",\"publisher\":{\"@id\":\"https:\/\/stage.datumdental.wee.co.il\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/stage.datumdental.wee.co.il\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/stage.datumdental.wee.co.il\/en\/#organization\",\"name\":\"Regenerative Solutions | Dentsply Sirona\",\"url\":\"https:\/\/stage.datumdental.wee.co.il\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/stage.datumdental.wee.co.il\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/stage.datumdental.wee.co.il\/wp-content\/uploads\/2023\/09\/Dentsply-Sirona-Regenerative-Solutions-logo-1.png\",\"contentUrl\":\"https:\/\/stage.datumdental.wee.co.il\/wp-content\/uploads\/2023\/09\/Dentsply-Sirona-Regenerative-Solutions-logo-1.png\",\"width\":1667,\"height\":262,\"caption\":\"Regenerative Solutions | Dentsply Sirona\"},\"image\":{\"@id\":\"https:\/\/stage.datumdental.wee.co.il\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/stage.datumdental.wee.co.il\/en\/#\/schema\/person\/6718398796ad644a693f2686ccfc7828\",\"name\":\"Steve\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/stage.datumdental.wee.co.il\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/74aa9713112e88544ba8f3bcb66a792d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/74aa9713112e88544ba8f3bcb66a792d?s=96&d=mm&r=g\",\"caption\":\"Steve\"},\"url\":\"https:\/\/stage.datumdental.wee.co.il\/en\/author\/steav\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"OSSIX\u00ae VOLUMAX \u2014 New Collagen Scaffold for GBR and GTRwith Improved Volume Maintaining Features \u2014 Receives FDA 510(k) Clearance - Regenerative Solutions | Dentsply Sirona","description":"Lod, Israel and AAP San Diego, CA, September 11th 2016, \/PRNewswire\/-- Datum Dental announced that OSSIX\u00ae VOLUMAX has received FDA 510(k) clearance, enabling the company to commercially market","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/stage.datumdental.wee.co.il\/en\/ossix-volumax-new-collagen-scaffold-for-gbr-and-gtr-with-improved-volume-maintaining-features-receives-fda-510k-clearance-2\/","og_locale":"en_US","og_type":"article","og_title":"OSSIX\u00ae VOLUMAX \u2014 New Collagen Scaffold for GBR and GTRwith Improved Volume Maintaining Features \u2014 Receives FDA 510(k) Clearance - Regenerative Solutions | Dentsply Sirona","og_description":"Lod, Israel and AAP San Diego, CA, September 11th 2016, \/PRNewswire\/-- Datum Dental announced that OSSIX\u00ae VOLUMAX has received FDA 510(k) clearance, enabling the company to commercially market","og_url":"https:\/\/stage.datumdental.wee.co.il\/en\/ossix-volumax-new-collagen-scaffold-for-gbr-and-gtr-with-improved-volume-maintaining-features-receives-fda-510k-clearance-2\/","og_site_name":"Regenerative Solutions | Dentsply Sirona","article_published_time":"2016-09-11T15:28:36+00:00","article_modified_time":"2019-03-10T15:10:10+00:00","og_image":[{"width":896,"height":632,"url":"https:\/\/stage.datumdental.wee.co.il\/wp-content\/uploads\/2016\/09\/ossix-volumax.jpg","type":"image\/jpeg"}],"author":"Steve","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Steve","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/stage.datumdental.wee.co.il\/en\/ossix-volumax-new-collagen-scaffold-for-gbr-and-gtr-with-improved-volume-maintaining-features-receives-fda-510k-clearance-2\/#article","isPartOf":{"@id":"https:\/\/stage.datumdental.wee.co.il\/en\/ossix-volumax-new-collagen-scaffold-for-gbr-and-gtr-with-improved-volume-maintaining-features-receives-fda-510k-clearance-2\/"},"author":{"name":"Steve","@id":"https:\/\/stage.datumdental.wee.co.il\/en\/#\/schema\/person\/6718398796ad644a693f2686ccfc7828"},"headline":"OSSIX\u00ae VOLUMAX \u2014 New Collagen Scaffold for GBR and GTRwith Improved Volume Maintaining Features \u2014 Receives FDA 510(k) Clearance","datePublished":"2016-09-11T15:28:36+00:00","dateModified":"2019-03-10T15:10:10+00:00","mainEntityOfPage":{"@id":"https:\/\/stage.datumdental.wee.co.il\/en\/ossix-volumax-new-collagen-scaffold-for-gbr-and-gtr-with-improved-volume-maintaining-features-receives-fda-510k-clearance-2\/"},"wordCount":514,"commentCount":0,"publisher":{"@id":"https:\/\/stage.datumdental.wee.co.il\/en\/#organization"},"articleSection":["Press Releases"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/stage.datumdental.wee.co.il\/en\/ossix-volumax-new-collagen-scaffold-for-gbr-and-gtr-with-improved-volume-maintaining-features-receives-fda-510k-clearance-2\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/stage.datumdental.wee.co.il\/en\/ossix-volumax-new-collagen-scaffold-for-gbr-and-gtr-with-improved-volume-maintaining-features-receives-fda-510k-clearance-2\/","url":"https:\/\/stage.datumdental.wee.co.il\/en\/ossix-volumax-new-collagen-scaffold-for-gbr-and-gtr-with-improved-volume-maintaining-features-receives-fda-510k-clearance-2\/","name":"OSSIX\u00ae VOLUMAX \u2014 New Collagen Scaffold for GBR and GTRwith Improved Volume Maintaining Features \u2014 Receives FDA 510(k) Clearance - Regenerative Solutions | Dentsply Sirona","isPartOf":{"@id":"https:\/\/stage.datumdental.wee.co.il\/en\/#website"},"datePublished":"2016-09-11T15:28:36+00:00","dateModified":"2019-03-10T15:10:10+00:00","description":"Lod, Israel and AAP San Diego, CA, September 11th 2016, \/PRNewswire\/-- Datum Dental announced that OSSIX\u00ae VOLUMAX has received FDA 510(k) clearance, enabling the company to commercially market","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/stage.datumdental.wee.co.il\/en\/ossix-volumax-new-collagen-scaffold-for-gbr-and-gtr-with-improved-volume-maintaining-features-receives-fda-510k-clearance-2\/"]}]},{"@type":"WebSite","@id":"https:\/\/stage.datumdental.wee.co.il\/en\/#website","url":"https:\/\/stage.datumdental.wee.co.il\/en\/","name":"Regenerative Solutions | Dentsply Sirona","description":"Regenerative Solutions | Dentsply Sirona","publisher":{"@id":"https:\/\/stage.datumdental.wee.co.il\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/stage.datumdental.wee.co.il\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/stage.datumdental.wee.co.il\/en\/#organization","name":"Regenerative Solutions | Dentsply Sirona","url":"https:\/\/stage.datumdental.wee.co.il\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stage.datumdental.wee.co.il\/en\/#\/schema\/logo\/image\/","url":"https:\/\/stage.datumdental.wee.co.il\/wp-content\/uploads\/2023\/09\/Dentsply-Sirona-Regenerative-Solutions-logo-1.png","contentUrl":"https:\/\/stage.datumdental.wee.co.il\/wp-content\/uploads\/2023\/09\/Dentsply-Sirona-Regenerative-Solutions-logo-1.png","width":1667,"height":262,"caption":"Regenerative Solutions | Dentsply Sirona"},"image":{"@id":"https:\/\/stage.datumdental.wee.co.il\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/stage.datumdental.wee.co.il\/en\/#\/schema\/person\/6718398796ad644a693f2686ccfc7828","name":"Steve","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stage.datumdental.wee.co.il\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/74aa9713112e88544ba8f3bcb66a792d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/74aa9713112e88544ba8f3bcb66a792d?s=96&d=mm&r=g","caption":"Steve"},"url":"https:\/\/stage.datumdental.wee.co.il\/en\/author\/steav\/"}]}},"_links":{"self":[{"href":"https:\/\/stage.datumdental.wee.co.il\/en\/wp-json\/wp\/v2\/posts\/1235\/"}],"collection":[{"href":"https:\/\/stage.datumdental.wee.co.il\/en\/wp-json\/wp\/v2\/posts\/"}],"about":[{"href":"https:\/\/stage.datumdental.wee.co.il\/en\/wp-json\/wp\/v2\/types\/post\/"}],"author":[{"embeddable":true,"href":"https:\/\/stage.datumdental.wee.co.il\/en\/wp-json\/wp\/v2\/users\/3\/"}],"replies":[{"embeddable":true,"href":"https:\/\/stage.datumdental.wee.co.il\/en\/wp-json\/wp\/v2\/comments\/?post=1235"}],"version-history":[{"count":4,"href":"https:\/\/stage.datumdental.wee.co.il\/en\/wp-json\/wp\/v2\/posts\/1235\/revisions\/"}],"predecessor-version":[{"id":1239,"href":"https:\/\/stage.datumdental.wee.co.il\/en\/wp-json\/wp\/v2\/posts\/1235\/revisions\/1239\/"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stage.datumdental.wee.co.il\/en\/wp-json\/wp\/v2\/media\/2002\/"}],"wp:attachment":[{"href":"https:\/\/stage.datumdental.wee.co.il\/en\/wp-json\/wp\/v2\/media\/?parent=1235"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stage.datumdental.wee.co.il\/en\/wp-json\/wp\/v2\/categories\/?post=1235"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stage.datumdental.wee.co.il\/en\/wp-json\/wp\/v2\/tags\/?post=1235"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}